Vaccination dry run: 125 beneficiaries each in 4 states register for shots

The dry run was being carried out in Krishna district in AP, in Rajkot and Gandhinagar in Gujarat, Ludhiana and Shaheed Bhagat Singh Nagar in Punjab, Sonitpur and Nalbari districts in Assam

Topics
Coronavirus Vaccine | Coronavirus

Press Trust of India 

Coronavirus, vaccine, covid, drugs, clinical trials
The dry run was being carried out in five locations with 25 test beneficiaries (healthcare workers) for each session

As the country eagerly awaits an expected vaccination drive in January, at least 125 intended beneficiaries each in four states who had registered on the Co-WIN App were on Monday sent SMSes informing them about the time and place of their 'Covid-19 vaccination' under a mock-drill to administer the shots at designated centres.

The two-day end-to-end dry run was being carried out in Krishna district in Andhra Pradesh, in Rajkot and Gandhinagar in Gujarat, Ludhiana and Shaheed Bhagat Singh Nagar (Nawanshahr) in Punjab and Sonitpur and Nalbari districts in Assam.

It is being conducted to test the laid out mechanisms for Covid-19 vaccination in the states and provide insights into any gaps to be addressed before the commencement of the actual vaccination drive, according to officials.

They said said the exercise tested the functionality of Co-WIN, which is an online platform for monitoring the delivery of Covid-19 vaccine, deployment of team members, checking cold storage, transportation arrangements and other arrangements while following all necessary protocols.

Krishna district Collector A Md Imtiyaz, who inaugurated the dry run at the urban primary health centre at Prakash Nagar in Vijayawada, said "the (dummy) vaccine was transported from the central storage facility to cold chain points at various places".

The dry run was being carried out in five locations with 25 test beneficiaries (healthcare workers) for each session.

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

Read our full coverage on Coronavirus Vaccine
First Published: Mon, December 28 2020. 23:38 IST
RECOMMENDED FOR YOU